Given the rapid rise in female MS incidence (see below), addressing the question whether DRB1*1501 DNA hypomethylation functions as an epigenetic switch controlling gene expression and MS risk is an urgent research priority. Here, HLA-DRB1 is linked to myeloid sarcoma.